JP2006500337A - 塩酸ベナゼプリルの結晶多形形態および非晶質形態 - Google Patents

塩酸ベナゼプリルの結晶多形形態および非晶質形態 Download PDF

Info

Publication number
JP2006500337A
JP2006500337A JP2004525233A JP2004525233A JP2006500337A JP 2006500337 A JP2006500337 A JP 2006500337A JP 2004525233 A JP2004525233 A JP 2004525233A JP 2004525233 A JP2004525233 A JP 2004525233A JP 2006500337 A JP2006500337 A JP 2006500337A
Authority
JP
Japan
Prior art keywords
phenylpropyl
ethoxycarbonyl
tetrahydro
amino
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004525233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500337A5 (https=
Inventor
ファン・デル・スハーフ，パウル・アドリアーン
マルコッリ，クラウディア
ブラッター，フリッツ
シェラギエヴィッツ，マルティン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba Spezialitaetenchemie Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Spezialitaetenchemie Holding AG filed Critical Ciba Spezialitaetenchemie Holding AG
Publication of JP2006500337A publication Critical patent/JP2006500337A/ja
Publication of JP2006500337A5 publication Critical patent/JP2006500337A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2004525233A 2002-07-26 2003-07-17 塩酸ベナゼプリルの結晶多形形態および非晶質形態 Withdrawn JP2006500337A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02405653 2002-07-26
PCT/EP2003/007771 WO2004013105A1 (en) 2002-07-26 2003-07-17 Crystalline polymorphic and amorphous forms of benazepril hydrochloride

Publications (2)

Publication Number Publication Date
JP2006500337A true JP2006500337A (ja) 2006-01-05
JP2006500337A5 JP2006500337A5 (https=) 2006-08-31

Family

ID=31198001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004525233A Withdrawn JP2006500337A (ja) 2002-07-26 2003-07-17 塩酸ベナゼプリルの結晶多形形態および非晶質形態

Country Status (6)

Country Link
US (1) US20050107359A1 (https=)
EP (1) EP1525189A1 (https=)
JP (1) JP2006500337A (https=)
AU (1) AU2003250086A1 (https=)
CA (1) CA2492949A1 (https=)
WO (1) WO2004013105A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506919A (ja) * 2011-07-12 2014-03-20 サムジン ファーマシューティカル カンパニー，リミテッド クロピドグレル硫酸水素塩の球状粒子、これを含む薬学的組成物及びその製造方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1711493A2 (en) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Crystalline forms of zolmitriptan
WO2006084761A1 (en) * 2005-02-11 2006-08-17 Albemarle Corporation Crystalline polymorphs of benazepril hydrochloride
EP1891014B1 (en) * 2005-05-12 2009-03-11 Lupin Ltd. Improved process for crystallization of benazepril hydrochloride
WO2014080259A1 (en) * 2012-11-21 2014-05-30 Enaltec Labs Pvt. Ltd. Novel polymorphic forms of alcaftadine
CN104788376A (zh) * 2014-01-17 2015-07-22 海门慧聚药业有限公司 一种盐酸贝那普利的新晶型及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072352B1 (de) * 1981-08-11 1986-03-05 Ciba-Geigy Ag Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
JP2004513112A (ja) * 2000-10-31 2004-04-30 チバ　スペシャルティ　ケミカルズ　ホールディング　インコーポレーテッド フルバスタチンナトリウムの結晶形
PL361912A1 (en) * 2000-10-31 2004-10-04 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
EP1345903A1 (en) * 2000-12-21 2003-09-24 Ciba SC Holding AG Crystalline forms of cerivastatin sodium
WO2003013512A2 (en) * 2001-08-03 2003-02-20 Ciba Specialty Chemicals Holding Inc. Crystalline forms of fluvastatin sodium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506919A (ja) * 2011-07-12 2014-03-20 サムジン ファーマシューティカル カンパニー，リミテッド クロピドグレル硫酸水素塩の球状粒子、これを含む薬学的組成物及びその製造方法

Also Published As

Publication number Publication date
AU2003250086A1 (en) 2004-02-23
EP1525189A1 (en) 2005-04-27
CA2492949A1 (en) 2004-02-12
WO2004013105A1 (en) 2004-02-12
US20050107359A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
US20230322680A1 (en) Crystalline forms of pitavastatin calcium
KR20080064908A (ko) 카르베딜올
US8686153B2 (en) Lenalidomide salts
JP2006500337A (ja) 塩酸ベナゼプリルの結晶多形形態および非晶質形態
ZA200210282B (en) Carvedilol.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060710

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060710

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080502